Stock Analysts

Toronto-Dominion Posts Strong 4Q (EPHC) (RY) (TD)

Last week, The Toronto-Dominion Bank ( TD ) reported its fiscal fourth quarter 2012 (ended Oct 31) adjusted earnings per share of C$1.83, which compared favorably with the year-ago earnings of C$1.77. Moreover, adjusted net income came in at C$1.76 billion ($1.78 billion), up 6.1% from the year-ago period. Improved results were driven by enhanced revenue as well as strong assets and profitability ratio in the quarter […]

Stock Analysts

Data Presented on BMY/PFE’s Eliquis (BMY) (PFE)

Recently, Bristol-Myers Squibb Company ( BMY ) and partner Pfizer Inc. ( PFE ) announced encouraging data from a phase III study (AMPLIFY-EXT: n=2,486), which evaluated their anti-clotting drug Eliquis (apixaban) for the prevention of recurrent venous thromboembolism (VTE). The randomized, double-blind, multicenter study evaluated the drug across two doses – 2.5 mg and 5 mg versus placebo in patients, who had been previously treated for VTE. […]